Dr Mark Young
Projects as PI
1 of 3
- Assessing the anticancer properties of Biocyanin SLH (03/07/2018 - 27/08/2018)
- Developing P2X7 antagonists for the treatment of inflammatory eye disease (01/10/2019 - 31/12/2022)
- Development of panspecific snake antivenom for use throughtout sub-Sahara Africa (01/07/2018 - 15/04/2023)
- Extraction and purification of a novel hemocyanin through implementation of new techniques (01/08/2018 - 30/09/2019)
- Extraction and purification of a novel hemocyanin through implementation of new techniques (01/09/2018 - 31/08/2019)
Projects as Co-Investigator
- A label-free tool to unravel the dynamics of lipid bilayers containing single membrane proteins: iGOR microscopy (15/02/2019 - 31/08/2020)
- Comparative proteomics of sperm (01/04/2024 - 30/06/2024)
- Structural determination of human P2X4 using two-dimensional crystography (01/09/2009 - 31/01/2011)
Research Datasets
- A structure determination protocol based on combined analysis of 3D-ED data, powder XRD data, solid-state NMR data and DFT-D calculations reveals the structure of a new polymorph of L-tyrosine: data - Smalley CJH, Hoskyns HE, Hughes CE, et al. (2023). Cardiff University. 10.17035/d.2022.0164412918. X-ray Diffraction (Crystal) Crystal structure Solid-state NMR Electron Diffraction
- Solid-state structural properties of alloxazine determined from powder XRD data in conjunction with DFT-D calculations and solid-state NMR spectroscopy: unravelling the tautomeric identity and pathways for tautomeric interconversion - data - Smalley CJH, Logsdail AJ, Hughes CE, et al. (2021). Cardiff University. 10.17035/d.2021.0140049329. X-ray Diffraction (Crystal) Crystal structure Solid-state NMR
